Market revenue in 2023 | USD 5.4 million |
Market revenue in 2030 | USD 17.3 million |
Growth rate | 18.1% (CAGR from 2023 to 2030) |
Largest segment | Cytokines & growth factors |
Fastest growing segment | Cytokines & Growth Factors |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 25.93% in 2023. Horizon Databook has segmented the Argentina research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
Argentina has a robust and growing biopharmaceutical industry. Various collaboration & government initiatives are anticipated to drive the growth of the market in the country. For instance, in November 2022, the National Comprehensive Cancer Network (NCCN), comprising cancer centers across the U.S., announced its partnership with the Latin American and Caribbean Society of Medical Oncology (SLACOM) for a collaborative initiative.
This joint initiative was expected to enhance accessibility to breast cancer care in Argentina. Moreover, Argentina has undergone a noticeable evolution in the clinical trials domain, marked by the usage of biomarkers.
For instance, according to the article published by NIH in July 2023, the advancement of precision medicine strategies in Argentina, where, biomarkers and genomic data had an essential part for better diagnostics study and treatments.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into Argentina research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account